ACLX
Arcellx Inc

468
Mkt Cap
$3.93B
Volume
575,247.00
52W High
$94.07
52W Low
$47.86
PE Ratio
-17.36
ACLX Fundamentals
Price
$68.03
Prev Close
$66.94
Open
$67.95
50D MA
$67.96
Beta
1.17
Avg. Volume
947,940.50
EPS (Annual)
-$2.00
P/B
8.92
Rev/Employee
$662,184.05
Loading...
Loading...
News
all
press releases
Arcellx, Inc. (NASDAQ:ACLX) Given Average Recommendation of "Moderate Buy" by Brokerages
Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) has earned an average rating of "Moderate Buy" from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. One...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Arcellx (NASDAQ:ACLX) Given "Buy" Rating at Needham & Company LLC
Needham & Company LLC restated a "buy" rating and issued a $105.00 price target on shares of Arcellx in a research note on Thursday...
MarketBeat·3d ago
News Placeholder
Pathway Capital Management LP Takes $4.19 Million Position in Arcellx, Inc. $ACLX
Pathway Capital Management LP purchased a new position in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·5d ago
News Placeholder
Y Intercept Hong Kong Ltd Takes $1.27 Million Position in Arcellx, Inc. $ACLX
Y Intercept Hong Kong Ltd purchased a new position in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·7d ago
News Placeholder
Arcellx Director Sells 6,000 Shares for $450,000
Key PointsDavid Charles Lubner, a director at Arcellx, exercised 6,000 shares, which were sold immediately on Jan. 20, 2026, resulting in a transaction value of approximately $450,000...
Nasdaq News: Markets·8d ago
News Placeholder
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, is...
Business Wire·18d ago
News Placeholder
Is Arcellx (ACLX) Stock Outpacing Its Medical Peers This Year?
Here is how Arcellx, Inc. (ACLX) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
Zacks·18d ago
News Placeholder
Bullish Two Hundred Day Moving Average Cross - ACLX
In trading on Tuesday, shares of Arcellx Inc (Symbol: ACLX) crossed above their 200 day moving average of $71.17, changing hands as high as $76.50 per share. Arcellx Inc shares are currently trading...
Nasdaq News: Markets·19d ago
News Placeholder
Interesting ACLX Put And Call Options For March 20th
Investors in Arcellx Inc (Symbol: ACLX) saw new options become available this week, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACLX...
Nasdaq News: Markets·23d ago
News Placeholder
Christopher Heery Sells 5,882 Shares of Arcellx (NASDAQ:ACLX) Stock
Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Christopher Heery sold 5,882 shares of the stock in a transaction that occurred on Wednesday, January 14th. The stock was sold at an average...
MarketBeat·25d ago
<
1
2
...
>

Latest ACLX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.